IRIS Accounts Production v25.2.0.378 10278217 Board of Directors 1.4.23 31.12.23 31.12.23 29.9.25 false true false false true false Auditors Opinion iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh102782172023-03-31102782172023-12-31102782172023-04-012023-12-31102782172022-03-31102782172022-04-012023-03-31102782172023-03-3110278217ns15:EnglandWales2023-04-012023-12-3110278217ns14:PoundSterling2023-04-012023-12-3110278217ns10:Director12023-04-012023-12-3110278217ns10:PrivateLimitedCompanyLtd2023-04-012023-12-3110278217ns10:SmallEntities2023-04-012023-12-3110278217ns10:Audited2023-04-012023-12-3110278217ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012023-12-3110278217ns10:SmallCompaniesRegimeForAccounts2023-04-012023-12-3110278217ns10:FullAccounts2023-04-012023-12-3110278217ns10:Director32023-04-012023-12-3110278217ns10:RegisteredOffice2023-04-012023-12-3110278217ns5:CurrentFinancialInstruments2023-12-3110278217ns5:CurrentFinancialInstruments2023-03-3110278217ns5:ShareCapital2023-12-3110278217ns5:ShareCapital2023-03-3110278217ns5:RetainedEarningsAccumulatedLosses2023-12-3110278217ns5:PlantMachinery2023-03-3110278217ns5:PlantMachinery2023-04-012023-12-3110278217ns5:PlantMachinery2023-12-3110278217ns5:PlantMachinery2023-03-3110278217ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-12-3110278217ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3110278217ns5:CurrentFinancialInstruments2023-04-012023-12-3110278217ns5:WithinOneYear2023-12-3110278217ns5:WithinOneYear2023-03-3110278217ns5:BetweenOneFiveYears2023-12-3110278217ns5:BetweenOneFiveYears2023-03-3110278217ns5:AllPeriods2023-12-3110278217ns5:AllPeriods2023-03-31
REGISTERED NUMBER: 10278217 (England and Wales)















Financial Statements for the Period 1 April 2023 to 31 December 2023

for

Scinopsis Ltd

Scinopsis Ltd (Registered number: 10278217)

Contents of the Financial Statements
for the Period 1 April 2023 to 31 December 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Scinopsis Ltd

Company Information
for the Period 1 April 2023 to 31 December 2023







DIRECTORS: P T Flanagan
C M Henderson





REGISTERED OFFICE: 27 Old Gloucester Street
London
WC1N 3AX





REGISTERED NUMBER: 10278217 (England and Wales)





AUDITORS: Ensors
Saxon House
Moseley's Farm Business Centre
Fornham All Saints
Bury St Edmunds
IP28 6JY

Scinopsis Ltd (Registered number: 10278217)

Balance Sheet
31 December 2023

31.12.23 31.3.23
As restated
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,899 6,939

CURRENT ASSETS
Debtors 5 234,229 171,127
Cash at bank and in hand 143,603 237,901
377,832 409,028
CREDITORS
Amounts falling due within one year 6 328,725 405,037
NET CURRENT ASSETS 49,107 3,991
TOTAL ASSETS LESS CURRENT
LIABILITIES

52,006

10,930

CAPITAL AND RESERVES
Called up share capital 10,002 10,002
Retained earnings 42,004 928
52,006 10,930

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by:





P T Flanagan - Director


Scinopsis Ltd (Registered number: 10278217)

Notes to the Financial Statements
for the Period 1 April 2023 to 31 December 2023


1. STATUTORY INFORMATION

Scinopsis Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Reporting period
The accounting period to 31 December 2023 is a nine month period. The comparative amounts presented in the financial statements (included the related notes) are for a twelve month period therefore are not entirely comparable. This was done to bring the financial period in line with that of the parent company.

Going concern
The financial statements have been prepared on a going concern basis. The directors have assessed the company’s financial position and, having made appropriate enquiries, consider that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover
Turnover is recognised in accordance with Section 23 of FRS 102.
Turnover from the provision of services is recognised in the profit and loss account when the outcome of the transaction can be estimated reliably.
Where services are provided over a period of time, turnover is recognised by reference to the stage of completion of the transaction at the reporting date, provided that the stage of completion and expected recoverability can be measured reliably.
In cases where the outcome cannot be estimated reliably, turnover is recognised only to the extent that recoverable expenses incurred are expected to be reimbursed.
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and VAT.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Property - 7 Years straight line
Plant and Machinery - 3 years straight line

Scinopsis Ltd (Registered number: 10278217)

Notes to the Financial Statements - continued
for the Period 1 April 2023 to 31 December 2023


2. ACCOUNTING POLICIES - continued

Financial instruments
The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's statement of financial position when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Cash and Cash Equivalents
The financial statements have been prepared on a going concern basis. The directors have assessed the company’s financial position and, having made appropriate enquiries, consider that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Basic financial assets
Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade payables are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Scinopsis Ltd (Registered number: 10278217)

Notes to the Financial Statements - continued
for the Period 1 April 2023 to 31 December 2023


2. ACCOUNTING POLICIES - continued

Foreign currencies
Transactions in currencies other than pound sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of non-current assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Intercompany recharges
Intercompany transactions are recorded at the value agreed between group entities and are recognised in accordance with the substance of the arrangement.
Recharges for services or shared resources are recognised as income or expense in the period in which the services are provided.
Recharges are calculated based on a percentage of revenue earned from the customer, with the percentage determined by the group to reflect an arm’s length basis.
The basis of allocation is reviewed periodically to ensure it remains reasonable, consistent, and reflective of the actual service contribution.

Costing Recharges
Costing recharges relate to the allocation of direct and indirect costs incurred on behalf of other entities or departments. These are recognised on an accruals basis, reflecting the period in which the underlying costs are incurred.
The basis of allocation is reviewed periodically to ensure it remains reasonable and consistent with the nature of the services provided.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 9 (2023 - 11 ) .

Scinopsis Ltd (Registered number: 10278217)

Notes to the Financial Statements - continued
for the Period 1 April 2023 to 31 December 2023


4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023 53,706
Disposals (939 )
At 31 December 2023 52,767
DEPRECIATION
At 1 April 2023 46,767
Charge for period 3,884
Eliminated on disposal (783 )
At 31 December 2023 49,868
NET BOOK VALUE
At 31 December 2023 2,899
At 31 March 2023 6,939

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.3.23
As restated
£    £   
Trade debtors 86,665 100,276
Other debtors 147,564 70,851
234,229 171,127

Other debtors include £120,908 (31 March 23: £39,695) in Accrued Income, £2,257 (31 March 23: £3,213) in VAT recoverable, and £24,399 (31 March 23: £27,943) in prepaid expenses.

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.23 31.3.23
As restated
£    £   
Amounts owed to group undertakings 209,590 239,318
Taxation and social security 26,665 30,340
Other creditors 92,470 135,379
328,725 405,037

Included in other creditors for the March 2023 year end is a directors loan advanced to the company of £42,500. The loan was fully repaid during the December 2023 period end.

Scinopsis Ltd (Registered number: 10278217)

Notes to the Financial Statements - continued
for the Period 1 April 2023 to 31 December 2023


7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
31.12.23 31.3.23
As restated
£    £   
Within one year 39,000 29,250
Between one and five years 13,680 52,680
52,680 81,930

Operating lease commitments relate to land and buildings, the lease relates to a 5 year period due to expire in April 2025.
Since the year end the lease has not been renewed.

8. DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Opinion
In our opinion the financial statements:
- give a true and fair view of the state of the company's affairs at 31 December 2023 and of its profit for the Period then ended;
- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
- have been prepared in accordance with the requirements of the Companies Act 2006.

Senior Statutory Auditor: Christopher Barrett
Statutory Auditor: Ensors
Date 29/9/2025

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Windrose Veristat InvestmentHoldings, L.P.

Name & address of the highest-level entity which files publicly available financial statements: Veristat International Ireland Limited, 6th Floor, 2 Grand Canal Square, Dublin 2 D02 A342, Ireland

Scinopsis Ltd (Registered number: 10278217)

Notes to the Financial Statements - continued
for the Period 1 April 2023 to 31 December 2023


10. PRIOR YEAR ADJUSTMENT

During the year, the company made the following prior year adjustments in accordance with FRS 102 Section 10 - Accounting Policies, Estimates and Errors, and Section 10.13-10.15 for retrospective application of changes in accounting policy.

1. Correction of Error - Misapplication of Accounting Policy on Intercompany Recharges
An error was identified in the prior year financial statements relating to the inconsistent application of the accounting policy for intercompany recharges. Transactions were not recorded in line with the substance of the arrangements, resulting in:
Revenue understated by £526,102
Cost of sales understated by £281,054
Intercompany account understated (liability overstated) by £245,048

This error has been corrected retrospectively, resulting in an increase in net assets and retained earnings of £245,048 as at 31 March 2023.

2. Correction of Error - Recognition of Intercompany Recharges on an Invoice Basis
A further error was identified whereby intercompany recharges were recognised on an invoice basis rather than on an accruals basis. This resulted in:
For the year ended 31 March 2023:
Cost of sales overstated by £77,676
Retained earnings brought forward overstated by £77,676
For periods prior to 31 March 2023:
Retained earnings overstated by £55,676
Intercompany account overstated (liability understated) by £55,675

These errors have been corrected retrospectively, resulting in a total reduction in retained earnings brought forward of £133,352 and a corresponding increase in intercompany liabilities of £55,675.

3. Change in Accounting Policy - Recognition of Management Charge
The company has changed its accounting policy to recognise a management charge from a group entity. This change has been applied retrospectively in accordance with FRS 102 Section 10.8-10.12, resulting in:
Administrative expenses increased by £188,666
Intercompany account overstated (liability understated) by £188,666
This change ensures the financial statements reflect the revised accounting policy consistently across periods.

4. Correction of Error - Reclassification of wages
The company incorrect classified wages and salaries as administrative expenses rather than within cost of sales. As a result, a retrospective reclassification adjustment has been made to correct the accounts.
For the year ended 31 March 2023:
Cost of sales understated by £460,112
Administrative expenses overstated by £460,122

Summary of Impact on Profit or Loss - Year Ended 31 March 2023
The net impact of the above adjustments on the profit or loss for the year ended 31 March 2023 is as follows:
Increase in revenue: £526,102
Increase in cost of sales: £663,491
Decrease in administrative expenses: £271,446
Net increase in profit before tax: £134,058

Summary of Cumulative Impact on Balance Sheet as at 31 March 2023
Net increase in retained earnings / total equity: £707
Net decrease in intercompany liabilities: £707